Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: CALM-NET (EudraCT 2013-002194-22; NCT02075606) evaluated pre-treatment circulating tumour cell levels in patients with NETs as a predictor of response to lanreotide autogel (LAN).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Shah T, Caplin M, Khan M, Houchard A, Furnace M,
Keywords: neuroendocrine tumours, lanreotide, biomarkers,
#899 Evaluation of the Clinical Utility of Plasma Biomarkers in Diagnosis of Neuroendocrine Tumors
Introduction: Neuroendocrine tumors (NETs) are rare cancers that usually develop in the gastroenterohepatic system. Diagnostic workup of these tumors includes measurement of plasma levels of marker peptides. Clinical experience suggests that these markers may be misleading if used before histological or imaging evidence of a NET is available.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Lunberg-Adams M
Authors: Lunberg-Adams M, James A, Perros P,
Keywords: chromogranin A, neurokinin A, pancreatic polypeptide, neuroendocrine tumor diagnosis,
Introduction: Recent European investigations demonstrated that persistently elevated (> 50 pg/ml) plasma neurokinin A (NKA) levels are associated with poor short-term survival in patients with midgut neuroendocrine tumors (NETS).
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author:
Authors: Diebold A, Boudreaux J, Wang Y, Anthony L, Uhlhorn A,
Keywords: midgut, neuroendocrine tumors (NETs), Neurokinin A (NKA), survival,